In this episode of the CardioNerds Cardiovascular Prevention Series, we discuss the clinical implementation of glucagon-like peptide-1 (GLP-1) receptor agonists
In practice, most interest clusters around these real world goals: Skin quality and visible aging Wound healing support (when appropriate), which aligns with the principles of regenerative therapy Hair and scalp health conversations (still evolving, mixed quality evidence) Joint, tendon, connective tissue support as part of a bigger plan Recovery support, again in context And for some patients, the longevity benefit is simply this: better tissue repair capacity and less chronic inflammatory signaling can improve quality of life
visible thickness changes typically take 1224 weeks
Because the procedure is performed through a tiny puncture rather than a large incision, recovery is typically shorter and less disruptive than with surgical alternatives
If you're combining BPC-157 with other peptides, professional guidance can help ensure each one fits your goals